Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes. Aroda VR, Erhan U, Jelnes P, Meier JJ, et al. Diabetes Obes Metab 2023;25:1385-1397.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aroda VR, Erhan U, Jelnes P, Meier JJ, et al. Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes. Diabetes Obes Metab 2023;25:1385-1397.
PMID: 36700417